Post-translational control of the MEF2A transcriptional regulatory protein

Myocyte enhancer factor 2 (MEF2) transcriptional regulatory proteins are ke y regulators of muscle-specific gene expression and also play a general rol e in the cellular response to growth factors, cytokines and environmental s tressors, To identify signaling pathway components that might mediate these events, the potential role of MAP kinase and PKC signaling in the modulati on of MEF2A phosphorylation and transcriptional activity were therefore stu died. In transient transfection reporter assays, activated p38 MAP kinase p otently increased MEF2A trans-activating potential, PKC delta and E isotype s enhanced MEF2A transactivation to a lesser extent, while the ERK1/2 and J NK/SAPK pathways were without effect. A GAL4-based assay system showed that p38 MAP kinase and PKC delta target the MEF2A transactivation domain. We a lso observed an increase in p38 MAP kinase activity in congruence with the increase in MEF2A expression in differentiating primary muscle cells. COS c ells overexpressing MEF2A alone or with one of the kinases were metabolical ly labeled with [P-32]orthophosphate and MEF2A was immunoprecipitated using specific anti-MEF2A antibodies, MEF2A from cells co-transfected with activ ated p38 MAP kinase showed a decreased electrophoretic mobility due to phos phorylation. Subsequent phosphopeptide mapping and phosphoamino acid analys is indicated the appearance of several phoshopeptides due to p38 MAP kinase activation of MEF2A which were due to phosphorylation on serine and threon ine residues. These studies position MEF2A as a nuclear target for the p38 MAP kinase signaling pathway.